You are here: Home > News > Nephrology News Feeds > Toward Better Treatment for Lupus Nephritis
Written by NEJM Wednesday, 16 November 2011 18:00
Toward Better Treatment for Lupus Nephritis — NEJM
This article is available to subscribers.
now if you're a subscriber.

This article has no abstract; the first 100 words appear below.

Systemic lupus erythematosus is a prototypical autoimmune disease that can potentially involve every organ. Its clinical spectrum is therefore extremely heterogeneous and varies from relatively mild cases (e.g., involving only the skin or joints) to life-threatening manifestations, with renal impairment, severe cytopenias, or central nervous system disease, not to mention an increased rate of thromboembolic events.1

Kidney involvement (mainly glomerulonephritis) occurs in at least one third of patients with lupus and significantly affects survival.2 The initial clinical presentation of lupus nephritis ranges from asymptomatic proteinuria discovered on routine urinalysis to the nephrotic syndrome with or without renal impairment. Histologic examination . . .

Disclosure forms provided by the author are available with the full text of this article at NEJM.org.

Source Information

From the Rheumatology Department, Cliniques Universitaires Saint-Luc, Université catholique de Louvain, Brussels.

Read more: